Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Helen S Te und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Liver Diseases, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Tissue and Organ Procurement, Hepatitis B virus, Hepatitis B, Hepatitis B Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Systems Bureau, United States Department of Health and Human Services, Division of Transplantation.
Abstract (Originalsprache)
Background
Better access to direct‐acting antiviral (DAA) therapy has broadened the utilization of hepatitis C virus (HCV) nucleic acid testing (NAT) positive organs with excellent outcomes. However, DAA therapy has been associated with hepatitis B virus (HBV) reactivation.
Aim
To determine the risk of HBV transmission or reactivation with utilization of HBV core antibody positive (HBcAb+) and HCV NAT positive (HCV+) organs, which presumably required DAA therapy.
Methods
The number of HBcAb+ donors with delineated HCV NAT status was obtained from the Organ Procurement and Transplantation Network (OPTN) database. The number of unexpected HBV infections from transplanted organs adjudicated as “proven” or “probable” transmission was obtained from the OPTN Ad Hoc Disease Transmission Advisory Committee database. A chart review of the donors of “proven” or “probable” cases was conducted.
Results
From January 1, 2016, to December 31, 2021, 7735 organs were procured from 3767 HBcAb+ donors and transplanted into 7469 recipients; 545 (14.5%) donors were also HCV+. HBV transmission or reactivation occurred in seven recipients. The rate is not significantly different between recipients of HCV+ (0.18%, 2/1115) and the HCV NAT negative (HCV‐) organs (0.08%, 5/6354) ( p = 0.28) or between recipients of HCV+ and HCV‐ livers as well as non‐liver organs. HBV transmission or reactivation occurred within a median of 319 (range, 41–1117) days post‐transplant in the setting of missing, inadequate, or truncated prophylaxis.
Conclusion
HBV reactivation associated with DAA therapy for HBcAb+ HCV+ organs is less frequent than reported in the non‐transplant population, possibly due to the common use of HBV prophylaxis in the at‐risk transplant population. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Liver Diseases, Chicago, Illinois, USA.
- Division of Infectious Diseases, University of California San Francisco Medical Center, San Francisco, California, USA.
- Division of Infectious Diseases, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Denver, Colorado, USA.
- Division of Allergy & Infectious Diseases, Seattle, Washington, USA.
- Tennessee Donor Services, Nashville, Tennessee, USA.
ORCID-Profile: Helen S Te, Maheen Z Abidi, Sarah Taimur, Gerald J Berry, Anil J Trindade, Stephanie M Pouch, Lara Danziger-Isakov
Förderung
- Health Systems Bureau
- United States Department of Health and Human Services
- Division of Transplantation
- HRSA HHS
- NIA NIH HHS
- U.S. Department of Health and Human Services
- Health Resources and Services Administration
Zitieren
APA
Te, H. S., Lee, D. H., Woolley, A. E., Abidi, M. Z., Fisher, C., Sellers, M. T., Taimur, S., Livelli, T., Watkins, T., Handarova, D., Berry, G. J., Graves, R., Ho, C. S., Hughart, A. L., Kittleson, M., Marboe, C. C., Miller, R. A., Sharma, T. S., Trindade, A. J., …, & Danziger-Isakov, L. (2024). Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transplant Infectious Disease. https://doi.org/10.1111/tid.14305
Vancouver
Te HS, Lee DH, Woolley AE, Abidi MZ, Fisher C, Sellers MT, et al. Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transplant Infectious Disease. 2024. doi:10.1111/tid.14305
BibTeX
@article{Te2024,
author = {Te, Helen S and Lee, Dong Heun and Woolley, Ann E and Abidi, Maheen Z and Fisher, Cynthia and Sellers, Marty T and Taimur, Sarah and Livelli, Taylor and Watkins, Tamika and Handarova, Dzhuliyana and Berry, Gerald J and Graves, Riki and Ho, Chak-Sum and Hughart, Anna L and Kittleson, Michelle and Marboe, Charles C and Miller, Rachel A and Sharma, Tanvi S and Trindade, Anil J and Wood, R Patrick and Zaffiri, Lorenzo N and Pouch, Stephanie M and Danziger-Isakov, Lara},
title = {Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14305}
}
EUVIMED